{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T01:55:47Z","timestamp":1774230947108,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"DOI":"10.1007\/s10143-026-04235-8","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T01:10:59Z","timestamp":1774228259000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The beneficial effects of clazosentan on the perioperative management of patients with subarachnoid hemorrhage"],"prefix":"10.1007","volume":"49","author":[{"given":"Shinichiro","family":"Oku","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshinori","family":"Matsushige","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Takemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Hosogai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutaka","family":"Akino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutaka","family":"Horie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"4235_CR1","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.3171\/2022.2.Jns212914","volume":"137","author":"H Endo","year":"2022","unstructured":"Endo H, Hagihara Y, Kimura N, Takizawa K, Niizuma K, Togo O, Tominaga T (2022) Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients. J Neurosurg 137:1707\u20131717. https:\/\/doi.org\/10.3171\/2022.2.Jns212914","journal-title":"J Neurosurg"},{"key":"4235_CR2","doi-asserted-by":"publisher","first-page":"e314","DOI":"10.1161\/str.0000000000000436","volume":"54","author":"BL Hoh","year":"2023","unstructured":"Hoh BL, Ko NU, Amin-Hanjani S, Chou S-Y, Cruz-Flores S, Dangayach NS, Derdeyn CP, Du R, H\u00e4nggi D, Hetts SW, Ifejika NL, Johnson R, Keigher KM, Leslie-Mazwi TM, Lucke-Wold B, Rabinstein AA, Robicsek SA, Stapleton CJ, Suarez JI, Tjoumakaris SI, Welch BG (2023) 2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: A Guideline From the American Heart Association\/American Stroke Association. Stroke 54:e314\u2013e370. https:\/\/doi.org\/10.1161\/str.0000000000000436","journal-title":"Stroke"},{"key":"4235_CR3","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transpl 48:452\u2013458. https:\/\/doi.org\/10.1038\/bmt.2012.244","journal-title":"Bone Marrow Transpl"},{"key":"4235_CR4","doi-asserted-by":"publisher","first-page":"518","DOI":"10.3171\/2015.12.Jns151744","volume":"126","author":"T Karic","year":"2017","unstructured":"Karic T, R\u00f8e C, Nordenmark TH, Becker F, Sorteberg W, Sorteberg A (2017) Effect of early mobilization and rehabilitation on complications in aneurysmal subarachnoid hemorrhage. J Neurosurg 126:518\u2013526. https:\/\/doi.org\/10.3171\/2015.12.Jns151744","journal-title":"J Neurosurg"},{"key":"4235_CR5","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s00134-015-3763-8","volume":"41","author":"G Kayambu","year":"2015","unstructured":"Kayambu G, Boots R, Paratz J (2015) Early physical rehabilitation in intensive care patients with sepsis syndromes: a pilot randomised controlled trial. Intensive Care Med 41:865\u2013874. https:\/\/doi.org\/10.1007\/s00134-015-3763-8","journal-title":"Intensive Care Med"},{"key":"4235_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1385\/ncc:4:1:068","volume":"4","author":"KH Lee","year":"2006","unstructured":"Lee KH, Lukovits T, Friedman JA (2006) Triple-H therapy for cerebral vasospasm following subarachnoid hemorrhage. Neurocrit Care 4:68\u201376. https:\/\/doi.org\/10.1385\/ncc:4:1:068","journal-title":"Neurocrit Care"},{"key":"4235_CR7","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3340\/jkns.2024.0195","volume":"68","author":"SH Lee","year":"2025","unstructured":"Lee SH, Choi KS, Togo O, Park IS (2025) Comparison of Clazosentan and Nimodipine on Vasospasm and Vasospasm-Related Outcomes after Aneurysmal Subarachnoid Hemorrhage: A Post-hoc Propensity Score-Matched Analysis of Six Randomized Clinical Trials. J Korean Neurosurg Soc 68:392\u2013404. https:\/\/doi.org\/10.3340\/jkns.2024.0195","journal-title":"J Korean Neurosurg Soc"},{"key":"4235_CR8","doi-asserted-by":"publisher","first-page":"100253","DOI":"10.1016\/j.wnsx.2023.100253","volume":"21","author":"T Maeda","year":"2024","unstructured":"Maeda T, Okawara M, Osakabe M, Yamaguchi H, Maeda T, Kurita H (2024) Initial real-world experience of clazosentan for subarachnoid hemorrhage in Japan. World Neurosurg X 21:100253. https:\/\/doi.org\/10.1016\/j.wnsx.2023.100253","journal-title":"World Neurosurg X"},{"key":"4235_CR9","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1161\/strokeaha.119.025682","volume":"50","author":"SA Mayer","year":"2019","unstructured":"Mayer SA, Aldrich EF, Bruder N, Hmissi A, Macdonald RL, Viarasilpa T, Marr A, Roux S, Higashida RT (2019) Thick and Diffuse Subarachnoid Blood as a Treatment Effect Modifier of Clazosentan After Subarachnoid Hemorrhage. Stroke 50:2738\u20132744. https:\/\/doi.org\/10.1161\/strokeaha.119.025682","journal-title":"Stroke"},{"key":"4235_CR10","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3171\/2025.1.Jns242509","volume":"143","author":"S Muraoka","year":"2025","unstructured":"Muraoka S, Izumi T, Nishida K, Chr\u00e9tien B, Ishii K, Takeuchi I, Nishihori M, Goto S, Maesawa S, Shimato S, Kinkori T, Asai T, Suzuki O, Saito R (2025) RECOVER study: a multicenter retrospective cohort study and comparison of the efficacy and safety of clazosentan and fasudil in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 143:624\u2013633. https:\/\/doi.org\/10.3171\/2025.1.Jns242509","journal-title":"J Neurosurg"},{"key":"4235_CR11","doi-asserted-by":"publisher","first-page":"208","DOI":"10.2522\/ptj.20110334","volume":"93","author":"BF Olkowski","year":"2013","unstructured":"Olkowski BF, Devine MA, Slotnick LE, Veznedaroglu E, Liebman KM, Arcaro ML, Binning MJ (2013) Safety and feasibility of an early mobilization program for patients with aneurysmal subarachnoid hemorrhage. Phys Ther 93:208\u2013215. https:\/\/doi.org\/10.2522\/ptj.20110334","journal-title":"Phys Ther"},{"key":"4235_CR12","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1161\/strokeaha.110.604728","volume":"42","author":"M Sabri","year":"2011","unstructured":"Sabri M, Ai J, Macdonald RL (2011) Dissociation of vasospasm and secondary effects of experimental subarachnoid hemorrhage by clazosentan. Stroke 42:1454\u20131460. https:\/\/doi.org\/10.1161\/strokeaha.110.604728","journal-title":"Stroke"},{"key":"4235_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1001\/jamaneurol.2021.4346","volume":"79","author":"K Toyoda","year":"2022","unstructured":"Toyoda K, Yoshimura S, Nakai M, Koga M, Sasahara Y, Sonoda K, Kamiyama K, Yazawa Y, Kawada S, Sasaki M, Terasaki T, Miwa K, Koge J, Ishigami A, Wada S, Iwanaga Y, Miyamoto Y, Minematsu K, Kobayashi S (2022) Twenty-Year Change in Severity and Outcome of Ischemic and Hemorrhagic Strokes. JAMA Neurol 79:61\u201369. https:\/\/doi.org\/10.1001\/jamaneurol.2021.4346","journal-title":"JAMA Neurol"},{"key":"4235_CR14","doi-asserted-by":"publisher","first-page":"645811","DOI":"10.3389\/fneur.2021.645811","volume":"12","author":"M Zhang","year":"2021","unstructured":"Zhang M, Wang Q, Jiang Y, Shi H, Peng T, Wang M (2021) Optimization of Early Mobilization Program for Patients With Acute Ischemic Stroke: An Orthogonal Design. Front Neurol 12:645811. https:\/\/doi.org\/10.3389\/fneur.2021.645811","journal-title":"Front Neurol"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-026-04235-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-026-04235-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-026-04235-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T01:11:00Z","timestamp":1774228260000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-026-04235-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4235"],"URL":"https:\/\/doi.org\/10.1007\/s10143-026-04235-8","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"4 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval: The present study was approved by the local Institutional Review Board of Hiroshima City North Medical Center Asa Citizens Hospital (Approval No: 05-4-12).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"All study data were anonymized, and the requirement for informed consent was addressed using by the opt-out method.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"301"}}